For more Free Stock Tips click here >> http://www.ripplesadvisory.com/free-trial.php
Shares of Aurobindo Pharma were under pressure on Tuesday as it lost over 2 percent intraday due to regulatory issues. The US Food and Drug Administration (FDA) made some observations for the company’s Hyderabad unit and issued a Form 483 for the same. Brokerages, however, retained their buy call on the stock amid a few concerns from these observations.
Shares of Aurobindo Pharma were under pressure on Tuesday as it lost over 2 percent intraday due to regulatory issues. The US Food and Drug Administration (FDA) made some observations for the company’s Hyderabad unit and issued a Form 483 for the same. Brokerages, however, retained their buy call on the stock amid a few concerns from these observations.
No comments:
Post a Comment